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Human chorionic gonadotropin, hCG, a hormone which increases intracellular CAMP, provoked rapid (30 
s) and sustained (up to 30 min) increases in the levels of inositol mono-, bis- and trisphosphates (IP, IP2 
and IPj, respectively) in bovine luteal cells. LiCl (10 mM) enhanced inositol phosphate accumulation in re- 
sponse to hCG. Concentrationdependent increases in inositol phosphates, CAMP and progesterone accu- 
mulation were observed in hCG-treated luteal cells. hCG also induced rapid and concentration-dependent 
increases in cytosolic free Ca*+ as measured by quin 2 fluorescence. These findings demonstrate that hCG 
stimulates the phospholipase C-IP3 and diacylglycerol ‘second messenger’ system in the bovine corpus lu- 
teum. 
Ca2+ Gonadotropin Inositolphospholipid Inositolphosphate 
1. INTRODUCTION 
CAMP is recognized as a primary ‘second 
messenger’ of gonadotropin action in the corpus 
luteum [l]. Other studies have demonstrated that 
Ca2+ may also modulate the stimulatory action of 
LH and CAMP on progesterone synthesis [2-41, 
although it is not known whether gonadotropins 
alter intracellular Ca2+ levels. Recently, strong 
support has accumulated linking Ca2+ mobiliza- 
tion to increases in IP3 produced by receptor- 
mediated hydrolysis of PIP2 [5]. However, hor- 
mones which utilize CAMP as their intracellular se- 
cond messenger are not thought to increase second 
Abbreviations: hCG, human chorionic gonadotropin; 
W+li, cytosolic free calcium concentration; 
quin 2/AM, quin 2 tetraacetoxymethyl ester; IP3, ino- 
sitol trisphosphate; IP2, inositol bisphosphate; IP, ino- 
sitol phosphate; PI, phosphatidylinositol; PIP, phos- 
phatidylinositol 4-phosphate; PIP2, phosphatidylino- 
sitol 4,5-biphosphate; DAG, 1,2-diacylglycerol 
messengers derived 
(Corpus luteum) 
from inositol phospholipid 
hydrolysis [5-91. In this study, we have examined 
the effect of hCG on inositol phospholipid 
metabolism and [Ca2+]i as determined by quin 2 
fluorescence. We report that hCG, in addition to 
increasing CAMP, provokes increases in IP3 and 
[Ca’+]i in isolated bovine luteal cells. 
2. MATERIALS AND METHODS 
Corpora lutea were obtained from cows during 
early pregnancy, sliced, and dispersed with col- 
lagenase as described [lo]. Luteal cell preparations 
(l-l .5 x lo7 cells/ml) were preincubated for 3 h in 
medium containing myo-[2-3H]inositol (50 ,Ki/ 
ml) under an atmosphere of 95% 02, 5% CO2 at 
37°C. After this prelabeling period, the cells were 
washed and incubations were performed in 
triplicate with 0.5-l x lo6 viable cells, in a final 
volume of 0.5 ml of medium 199 containing 
25 mM Hepes and 0.1% BSA under an at- 
mosphere of 95% 02/5% CO2 at 37°C. After a 
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15 min incubation with or without 10 mM LiCl 
control media or hormones were added and the in- 
cubations were continued for up to 60 min. In- 
cubations were terminated by the addition of 
0.5 ml ice-cold 10% trichloroacetic acid. t3H]Ino- 
silo1 phosphates were purified as in [ 11,121 on col- 
umns (7 x 13 mm) of BioRad AG l-X8 
ion-exchange resin. 
In some experiments, the acid-precipitable pellet 
was extracted with 5 ml of chioroform/meth- 
anol/HCl(200: 100:0.75, by vol.) to determine the 
[3H]inositol content of cellular inositol 
phospholipids. Phospholipids were purified by 
thin-layer chromatography as described in [ 13 J . 
Progesterone and CAMP were measured by 
radioimmunoassay [ 1, lo]. 
Cytosolic free Ca2+ concentrations, [Ca2+]j, 
were measured by the method of Tsien et al. 1141 
with minor modifications as described [l 1,151. 
Luteal cells (lo7 cells/ml) were incubated with 
100 ,QM quin 2/AM. The unhydrolyzed ester was 
removed and cellular fluorescence (3-5 x lo6 
cells/ml) signals derived from the quin 2-Ca2+ 
complex were measured at an excitation 
wavelength of 339 nm (slit 5 nm) and emission 
wavelength of 492 nm (slit IO nm). All 
measurements were made using a Perkin-Elmer 
MPF-44A spectrofluorometer equipped with a 
magnetic stirrer and a thermostatted (at 37°C) cell 
holder. Maximum (F,,,& and minimum (Fmie) 
fluorescence were measured by rapidly saturating 
intracellular quin 2 with Ca2’ (&,& by 
permeabilizing the cells with 0.2% Triton, and by 
adding 5 mM EGTA in Tris buffer, pH 8.5, to 
determine the basal fluorescence (F;nin). No correc- 
tions were required for intrinsic fluorescence of the 
cells, media, hormones, and detergents. [Ca”]i 
was calculated according to the equation 
[11,14,15]: 
[Ca”], = 115 nM (F - Fmi”)/(Fm,, - F). 
3. RESULTS 
hCG provoked rapid (30 s) increases in the levels 
of inositol polyphosphates (fig. 1) with significant 
increases in IP Ievels occurring after l-2 min of 
hCG treatment. The initial rate of IP3 formation 
was greater than the rate of fP2 formation. Further 
increases in the levels of all inositol phosphates 
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Fig. I. Temporal profile of [3H)inositol phosphate 
accumulation in response to hCG. Bovine luteal cells 
were preincubated for 15 min with IO mM LX3 and 
were further incubated for up to 15 min with 2 W/ml of 
hCG. Results are means of triplicate determinations in a 
representative xperiment. Individual values varied less 
than 5% from the mean. Similar temporal relationships 
were observed in two other experiments. 
were observed throughout 60 min of incubation 
(not shown). In other experiments with 10 mM 
LiCl (to inhibit inositol phosphate phosphatase ac- 
tivity) a significant enhancement of hCG-induced 
accumulation of inositol monophosphate was 
observed in incubations lasting 15 min (table 1). In 
similar incubations, levels of J3H]PI were increased 
32% after 30 min treatment with hCG: 24834 f 
634 vs 32971 t- 1016 cpm/5 x 10’ cells (mean + 
SE, n = 3). Smaller increases (15-20%) were 
observed in labeling of PIP and PIP;? (not shown). 
To evaluate further the response to hCG, studies 
were conducted to determine the lowest effective 
concentration that would produce an increase in 
inositol phosphate levels. hCG at 2-20 IU/ml in 
incubations with 10 mM LiCl provoked maximal 
increases in inositol phosphate accumulation 
(fig.2). A slight stimulatory response was observed 
at 0.002 IU/ml of hCG. As expected, hCG also 
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Table 1 
Effect of LiCl on hCG-induced inositol phosphate accumulation in bovine 
luteal cells 
[3H]Inositol 
metabolite 
IP 
IPZ 
IP3 
Radioactivity in metabolite (cpm) 
- LiCl + LiCl 
Control hCG Control hCG 
4108 f 8 7146 f 68a 4561 3- 85” 9565 f 115a*b*c 
486 f 18 2564 f 51a 525 + 34 2567 z!z 63avb 
399 + 15 1727 + 40a 391 + 17 1898 f 29a*b 
a vs control (- LiCl), p < 0.05 
b vs control (+ LiCI), p < 0.05 
’ vs hCG (- LiCI), p < 0.05 
Bovine luteal cells were preincubated for 15 min with or without 10 mM 
LiCl and were further incubated for 15 min with 2 W/ml of hCG. Results 
are expressed as mean + SE, n = 3 
provoked concentration-dependent increases in 
CAMP and progesterone in these incubations 
(fig.2). However, exogenous CAMP (5 mM 
hCG WJ./ml) 
Fig.2. Dose dependency of hCG-induced increases in 
inositol phosphate, CAMP and progesterone 
accumulation. Bovine luteal ceils were preincubated for 
15 min with 10 mM LiCl and were further incubated for 
30 min with 0.002-20 W/ml of hCG. Results are means 
of 2 or 3 experiments after expression as a percentage of 
the maximal response observed in each experiment; the 
Fig.3. Effect of hCG on quin 2 fluorescence in isolated 
bovine luteal cells. The arrow indicates the addition of 
hCG (2 W/ml). Maximum and minimum fluorescence 
were determined by addition of Triton-X and EGTA, 
average variation was less than 10% of the mean. respectively. 
8-bromo-CAMP) and forskolin (10 PM) were 
unable to stimulate phosphoinositide metabolism 
(not shown). 
Fig.3 shows the effect of hCG on [Ca’+]i levels 
in quin 2-loaded bovine luteal cells. The increases 
in [Ca’+]i observed in response to hCG were max- 
imal in the first 30-60 s after hormone addition 
and were sustained at a slightly lower level for up 
to 10 min. As determined in 11 determinations 
from 3 separate cell preparations, hCG significant- 
ly increased [Ca’+]i (control vs hCG, 96 f 11 vs 
152 f 22 nM Ca2+, mean + SE, n = 11). hCG pro- 
voked similar increases in [Ca’+]r when luteal cells 
were incubated in Ca2+-free media (not shown). In 
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Ca*+-free medium containing 1 mM EGTA basal 
[Ca*+]i was reduced to 50-75 nM. Under these 
conditions hCG was able to increase [Ca*+]i, 
however, the response was reduced and was of 
shorter duration, lasting only 2-4 min. Similar to 
our results on IP3 accumulation, hCG provoked 
concentration-dependent increases in [Ca*+]i. 
Maximal increases in [Ca*+]i were observed at 
2 IU/ml of hCG (the increases in [Ca*+]i were 
56 r 11, 46 + 14 and 24 +- 13 nM Ca*+ for 2, 0.2, 
and 0.02 IU/ml of hCG, respectively). 
4. DISCUSSION 
The results of these studies demonstrate that the 
action of hCG in bovine luteal cells is associated 
with increases in inositol phosphate accumulation. 
The initial rate of formation of IP3 was greater 
than the rate of formation of IP2 or IP suggesting 
that one of the earliest effects of hCG on cellular 
inositol phospholipid metabolism is the hydrolysis 
of PIP*. It is unknown, however, whether IPz is 
formed directly from hCG-stimulated breakdown 
of PIP or if IP2 is a product of IP3 degradation. 
The more delayed increases in IP levels observed in 
these studies probably reflect the degradation of 
IP3 and IPz, as well as the formation of IP directly 
from PI hydrolysis. The sustained increases in the 
accumulation of inositol phosphates, together with 
the continued incorporation of [3H]inositol into 
inositol phospholipids in the presence of hCG, sug- 
gest that hCG-induced inositol phospholipid syn- 
thesis and hydrolysis is a continuous process. 
The present results also demonstrate that hCG 
increases [Ca*+]i in bovine luteal cells. The 
possibility that IP3 may be a second messenger for 
Ca*+ mobilization in bovine luteal cells is sup- 
ported by the similar dose-response and temporal 
relationships between hCG-induced IP3 formation 
and [Ca*+]i mobilization. IP3, through interaction 
with its intracellular eceptor [16], produces a tran- 
sient release of Ca2+ from an ATP-dependent, 
non-mitochondrial, vesicular pool, presumably the 
endoplasmic reticulum [5,17]. IP3 also mimics 
calcium-dependent processes when microinjected 
into a variety of cells [5,18]. In the ovary, Ca*+ 
participates in gonadotropin-induced CAMP pro- 
duction [4], steroid synthesis [2-41 and secretion 
[3], ornithine decarboxylase induction [ 191, pro- 
teoglycan production [20] and Cal+-dependent 
290 
protein phosphorylation [21-241. These studies 
further implicate Ca*+ in the action of 
gonadotropins, but the exact role of increases in 
IP3 and [Ca*+]i n response to hCG remains to be 
determined. 
Increased levels of DAG occur concomitantly 
with receptor-mediated phospholipase C-induced 
hydrolysis of inositol phospholipids [5-9,111. Like 
CAMP and Ca*+, DAG may play a central role in 
the action of hCG. DAG and the DAG-like tumor- 
promoting phorbol ester, 12-O-tetradecanoyl- 
phorbol 13-acetate, TPA, activate protein kinase C 
[6,25]. The presence of protein kinase C in the 
bovine corpus luteum [24] and the increase in in- 
ositol phospholipid hydrolysis in hCG-stimulated 
luteal cells also point to the involvement of protein 
kinase C in the action of hCG. TPA stimulates 
progesterone production in bovine luteal [26] and 
rat granulosa [27] cells by a mechanism indepen- 
dent of increases in CAMP. On the other hand, it 
has also been shown that TPA inhibits gonadotro- 
pin-induced steroidogenesis in bovine luteal [28] 
and rat granulosa cells [29]. Other recent studies 
suggest hat increases in DAG and activation of 
protein kinase C may be part of a negative feed- 
back mechanism for the regulation of cellular ac- 
tivity [30,31]. 
In summary, we have demonstrated that hCG 
stimulates rapid and concentration-dependent in- 
creases in IP3 and ]Ca*+]i. These studies provide 
the initial evidence that hCG may provoke its 
cellular response by stimulating two distinct se- 
cond messenger systems, (i) adenylate cyclase- 
CAMP and (ii) phospholipase C-IP3 and DAG. In 
studies to be reported elsewhere, we have also 
observed increased levels of IP3 in rat granulosa 
cells in response to luteinizing hormone [32] and 
hCG (unpublished). 
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